GlassScriptPhysician profile
Sally M Grogono
NPI 1437146263
$4,385.55
in general payments reported to CMS, 2019-2025
33 companies · $427 in 2025
The $427 reported for 2025 was more than what 77% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $434 · 2020: $167 · 2021: $444 · 2022: $718 · 2023: $1,444 · 2024: $752 · 2025: $427.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,430 · Education: $193.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,429.86 |
| Education | $192.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $535.46 | 2019-2023 | |
| Sumitomo Pharma America, INC. | $525.64 | 2023-2025 | Myfembree, Gemtesa |
| Astellas Pharma US INC | $453.15 | 2023-2025 | Veozah, Myrbetriq |
| Myovant Sciences INC. | $340.36 | 2021-2022 | |
| Myriad Women'S Health, INC. | $222.69 | 2023 | Myrisk |
| Exeltis, USA INC. | $217.67 | 2022-2025 | Slynd |
| Mayne Pharma Commercial LLC | $209.06 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $188.04 | 2019-2025 | |
| Shield Therapeutics INC | $174.88 | 2024-2025 | |
| Amag Pharmaceuticals, INC. | $167.32 | 2019-2020 | |
| Pfizer INC. | $145.31 | 2020-2024 | |
| Organon LLC | $144.81 | 2021-2025 | Nexplanon, Jada System |
| Hologic Sales and Service, LLC | $122.14 | 2019-2025 | Aptima, Novasure, Myosure Tissue Removal Device |
| Novo Nordisk INC | $116.24 | 2023-2025 | Wegovy |
| Avion Pharmaceuticals | $103.93 | 2020-2023 | Balcoltra |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Agile Therapeutics, INC. | $94.99 | 2021-2024 | Twirla |
| Millicent US INC | $77.29 | 2023-2025 | Intrarosa, Femlyv |
| Exact Sciences Corporation | $68.58 | 2023-2024 | Cologuard Collection Kit |
| Biogen, INC. | $66.77 | 2024-2025 | Zurzuvae |
| Daiichi Sankyo INC. | $56.01 | 2020-2024 | Injectafer |
| Evofem Biosciences, INC. | $55.97 | 2022-2024 | |
| Avanos Medical | $51.64 | 2019 | |
| Merck Sharp & Dohme LLC | $45.48 | 2019-2020 | |
| Davol INC. | $41.53 | 2024-2025 | Arista, Arista Ah Flexitip |
| Aspira Women'S Health INC | $28.27 | 2019-2024 | Ova1 |
| Meditrina | $22.99 | 2023 | |
| Coopersurgical, INC. | $22.51 | 2019 | |
| Roche Diagnostics Corporation | $20.74 | 2019 | |
| Axonics, INC. | $17.13 | 2024 | Bulkamid |
| Vertical Pharmaceuticals, LLC | $14.39 | 2019 | |
| Lupin INC. | $12.09 | 2019 | |
| Medtronic, INC. | $11.66 | 2021 | |
| Allergan, INC. | $10.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sally Grogono listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.